A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
Clinical trial NCT05950997 · RECRUITING
Trial details
- NCT number
- NCT05950997
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2026-05-31
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.